The Efficacy of Combining EGFR Monoclonal Antibody With Chemotherapy for Patients With Advanced Nonsmall Cell Lung Cancer: A Meta-Analysis From 9 Randomized Controlled Trials

Although epidermal growth factor receptor (EGFR) monoclonal antibodies (mAbs) have been proved synergistic effect when combined with cytotoxic agents for advanced nonsmall cell lung cancer (NSCLC), the results of relevant clinical trials remain controversial. The purpose of this meta-analysis was to...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Medicine (Baltimore)
Main Authors: Sheng, Jin, Yang, Yun-Peng, Zhao, Yuan-Yuan, Qin, Tao, Hu, Zhi-Huang, Zhou, Ting, Zhang, Ya-Xiong, Hong, Shao-Dong, Ma, Yu-Xiang, Zhao, Hong-Yun, Huang, Yan, Zhang, Li
Formato: Artigo
Idioma:Inglês
Publicado em: Wolters Kluwer Health 2015
Assuntos:
5700
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4602912/
https://ncbi.nlm.nih.gov/pubmed/26313787
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000001400
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados